Logo

Quidel

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.

Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations

The firm also announced a partnership with McKesson to enable more widespread distribution of its over-the-counter SARS-CoV-2 antigen test.

Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand

Quidel's guidance announcement cited an approximately 40 percent decrease in demand for its SARS-CoV-2 tests.

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.

Quidel Reports Delay in OTC COVID-19 Antigen Test Claims, Pours Cold Water on M&A Rumors
Premium

The firm's over-the-counter claim submission is delayed because it has been unable to find the required number of positive cases among asymptomatic people.

Feb 18, 2021

Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates

Feb 1, 2021

Fulgent Genetics Soars in January as GenomeWeb Index Begins 2021 up 10 Percent

Jan 13, 2021

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Jan 7, 2021

Quidel Preliminary Q4 Revenues Up Fivefold

Dec 23, 2020

Quidel Gets EUA for Rapid, Extraction-Free COVID-19 MDx on Solana System

Dec 1, 2020

Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth

Oct 30, 2020

Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'
Premium

Oct 29, 2020

Quidel Q3 Revenues More Than Triple, Beat Analyst Expectations

Oct 1, 2020

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Sep 18, 2020

People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More

Sep 8, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium

Sep 1, 2020

Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Aug 4, 2020

GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development

Jul 31, 2020

Facing 'Unfathomable' Demand, Quidel Ramps Up SARS-CoV-2 Test Production
Premium

Jul 31, 2020

NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics

Jul 30, 2020

Quidel Q2 Revenues Grow 86 Percent on COVID-19 Test Sales

Jul 7, 2020

Quidel Preliminary Q2 Revenues Jump More Than 86 Percent

Jul 2, 2020

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

May 19, 2020

Quidel Extractionless COVID PCR Test Get FDA Emergency Use Authorization

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.